1. Home
  2. ARWR vs CON Comparison

ARWR vs CON Comparison

Compare ARWR & CON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • CON
  • Stock Information
  • Founded
  • ARWR 2003
  • CON 1979
  • Country
  • ARWR United States
  • CON United States
  • Employees
  • ARWR N/A
  • CON N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • CON
  • Sector
  • ARWR Health Care
  • CON
  • Exchange
  • ARWR Nasdaq
  • CON NYSE
  • Market Cap
  • ARWR 1.7B
  • CON 2.8B
  • IPO Year
  • ARWR 1993
  • CON 2024
  • Fundamental
  • Price
  • ARWR $12.74
  • CON $21.70
  • Analyst Decision
  • ARWR Buy
  • CON Strong Buy
  • Analyst Count
  • ARWR 11
  • CON 7
  • Target Price
  • ARWR $41.44
  • CON $29.00
  • AVG Volume (30 Days)
  • ARWR 1.6M
  • CON 842.8K
  • Earning Date
  • ARWR 05-08-2025
  • CON 03-03-2025
  • Dividend Yield
  • ARWR N/A
  • CON 0.58%
  • EPS Growth
  • ARWR N/A
  • CON N/A
  • EPS
  • ARWR N/A
  • CON 1.46
  • Revenue
  • ARWR $2,500,000.00
  • CON $1,900,192,000.00
  • Revenue This Year
  • ARWR $4,380.43
  • CON $9.09
  • Revenue Next Year
  • ARWR $58.72
  • CON $6.61
  • P/E Ratio
  • ARWR N/A
  • CON $14.70
  • Revenue Growth
  • ARWR N/A
  • CON 3.38
  • 52 Week Low
  • ARWR $12.20
  • CON $18.89
  • 52 Week High
  • ARWR $30.41
  • CON $24.81
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 27.27
  • CON N/A
  • Support Level
  • ARWR $14.69
  • CON N/A
  • Resistance Level
  • ARWR $15.65
  • CON N/A
  • Average True Range (ATR)
  • ARWR 0.78
  • CON 0.00
  • MACD
  • ARWR -0.12
  • CON 0.00
  • Stochastic Oscillator
  • ARWR 13.07
  • CON 0.00

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

About CON CONCENTRA GROUP HOLDINGS PARENT INC

Concentra Group Holdings Parent Inc is a provider of occupational health services in the United States. The business is organized into three operating segments: occupational health centers, onsite health clinics, and other businesses.

Share on Social Networks: